BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 21261637)

  • 1. Resveratrol: a cardioprotective substance.
    Wu JM; Hsieh TC
    Ann N Y Acad Sci; 2011 Jan; 1215():16-21. PubMed ID: 21261637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of cardioprotection by resveratrol, a phenolic antioxidant present in red wine (Review).
    Wu JM; Wang ZR; Hsieh TC; Bruder JL; Zou JG; Huang YZ
    Int J Mol Med; 2001 Jul; 8(1):3-17. PubMed ID: 11408943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardioprotection of red wine: role of polyphenolic antioxidants.
    Das DK; Sato M; Ray PS; Maulik G; Engelman RM; Bertelli AA; Bertelli A
    Drugs Exp Clin Res; 1999; 25(2-3):115-20. PubMed ID: 10370873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dealcoholized red wine containing known amounts of resveratrol suppresses atherosclerosis in hypercholesterolemic rabbits without affecting plasma lipid levels.
    Wang Z; Zou J; Cao K; Hsieh TC; Huang Y; Wu JM
    Int J Mol Med; 2005 Oct; 16(4):533-40. PubMed ID: 16142383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Grapes, wines, resveratrol, and heart health.
    Bertelli AA; Das DK
    J Cardiovasc Pharmacol; 2009 Dec; 54(6):468-76. PubMed ID: 19770673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of red wine and wine polyphenol resveratrol on platelet aggregation in vivo and in vitro.
    Wang Z; Huang Y; Zou J; Cao K; Xu Y; Wu JM
    Int J Mol Med; 2002 Jan; 9(1):77-9. PubMed ID: 11745001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of proliferation and gene expression in cultured human aortic smooth muscle cells by resveratrol and standardized grape extracts.
    Wang Z; Chen Y; Labinskyy N; Hsieh TC; Ungvari Z; Wu JM
    Biochem Biophys Res Commun; 2006 Jul; 346(1):367-76. PubMed ID: 16759640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resveratrol: a promising agent in promoting cardioprotection against coronary heart disease.
    Penumathsa SV; Maulik N
    Can J Physiol Pharmacol; 2009 Apr; 87(4):275-86. PubMed ID: 19370081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Moderate red wine consumption and cardiovascular disease risk: beyond the "French paradox".
    Lippi G; Franchini M; Favaloro EJ; Targher G
    Semin Thromb Hemost; 2010 Feb; 36(1):59-70. PubMed ID: 20391297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Red Wine Consumption on Cardiovascular Health.
    Liberale L; Bonaventura A; Montecucco F; Dallegri F; Carbone F
    Curr Med Chem; 2019; 26(19):3542-3566. PubMed ID: 28521683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The red wine polyphenol, resveratrol, exerts acute direct actions on guinea-pig ventricular myocytes.
    Liew R; Stagg MA; MacLeod KT; Collins P
    Eur J Pharmacol; 2005 Sep; 519(1-2):1-8. PubMed ID: 16102748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The red wine hypothesis: from concepts to protective signalling molecules.
    Opie LH; Lecour S
    Eur Heart J; 2007 Jul; 28(14):1683-93. PubMed ID: 17561496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does white wine qualify for French paradox? Comparison of the cardioprotective effects of red and white wines and their constituents: resveratrol, tyrosol, and hydroxytyrosol.
    Dudley JI; Lekli I; Mukherjee S; Das M; Bertelli AA; Das DK
    J Agric Food Chem; 2008 Oct; 56(20):9362-73. PubMed ID: 18821770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut and microbial resveratrol metabolite profiling after moderate long-term consumption of red wine versus dealcoholized red wine in humans by an optimized ultra-high-pressure liquid chromatography tandem mass spectrometry method.
    Rotches-Ribalta M; Urpi-Sarda M; Llorach R; Boto-Ordoñez M; Jauregui O; Chiva-Blanch G; Perez-Garcia L; Jaeger W; Guillen M; Corella D; Tinahones FJ; Estruch R; Andres-Lacueva C
    J Chromatogr A; 2012 Nov; 1265():105-13. PubMed ID: 23089514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism-based inactivation of COX-1 by red wine m-hydroquinones: a structure-activity relationship study.
    Szewczuk LM; Penning TM
    J Nat Prod; 2004 Nov; 67(11):1777-82. PubMed ID: 15568761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential of resveratrol in the treatment of heart failure.
    Raj P; Louis XL; Thandapilly SJ; Movahed A; Zieroth S; Netticadan T
    Life Sci; 2014 Jan; 95(2):63-71. PubMed ID: 24361400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resveratrol and cardiovascular health--promising therapeutic or hopeless illusion?
    Tang PC; Ng YF; Ho S; Gyda M; Chan SW
    Pharmacol Res; 2014 Dec; 90():88-115. PubMed ID: 25151891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Red Wine Consumption and Cardiovascular Health.
    Castaldo L; Narváez A; Izzo L; Graziani G; Gaspari A; Minno GD; Ritieni A
    Molecules; 2019 Oct; 24(19):. PubMed ID: 31597344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardioprotective effect of resvaratrol pretreatment on myocardial ischemia-reperfusion induced injury in rats.
    Shen M; Jia GL; Wang YM; Ma H
    Vascul Pharmacol; 2006 Aug; 45(2):122-6. PubMed ID: 16765650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wine, resveratrol and health: a review.
    Guerrero RF; García-Parrilla MC; Puertas B; Cantos-Villar E
    Nat Prod Commun; 2009 May; 4(5):635-58. PubMed ID: 19445315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.